Dr. Sugarman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
624 N Broadway
Room 351
Baltimore, MD 21205Phone+1 410-955-3119Fax+1 410-955-5001
Education & Training
- Duke University HospitalResidency, Internal Medicine, 1986 - 1989
- Duke University School of MedicineClass of 1986
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- MD State Medical License 1990 - 2025
- NC State Medical License 1987 - 2004
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 2010
- Elected Member The American Society for Clinical Investigation, 2006
Publications & Presentations
PubMed
- Local context review by single institutional review boards: Results from a modified Delphi process.Stephanie R Morain, Juli Bollinger, Megan K Singleton, Mia Terkowitz, Christine Weston
Journal of Clinical and Translational Science. 2025-01-01 - Perceptions of Molecular HIV Surveillance Among Men Who Have Sex with Men in the United States.Marisol Valenzuela Lara, Travis H Sanchez, Juli M Bollinger, Gail Geller, Susan J Little
AIDS and Behavior. 2024-12-05 - Recall and Appraisal of the Risks, Benefits, and Objectives of Interrupting HIV Treatment in an HIV Cure-Related Study.Anastasia Korolkova, Samuel O Ndukwe, Lynda Dee, Steven G Deeks, Michael J Peluso
AIDS and Behavior. 2024-12-01
Journal Articles
- Safety, Tolerability, and Pharmacokinetics of Long-Acting Injectable Cabotegravir in Low-Risk HIV-Uninfected Individuals: HPTN 077, a Phase 2a Randomized Controlled TrialSusan H Eshleman, Joseph J Eron, Raphael J Landovitz, Myron S Cohen, Jeremy Sugarman, Mark A Marzinke, Craig W Hendrix, PLoS One
- Regional Differences Between People Who Inject Drugs in an HIV Prevention Trial Integrating Treatment and Prevention (HPTN 074): A Baseline AnalysisJeremy Sugarman, Susan H Eshleman, Journal of the International AIDS Society
- Perceptions of HIV Cure Research Among People Living with HIV in AustraliaJoseph D. Tucker, Jeremy Sugarman, J Sugarman, PLoS One
Press Mentions
- Summaries of Health Policy Coverage from Major News OrganizationsJune 24th, 2020
- A Professional Standard for Informed Consent for Stem Cell TherapiesAugust 12th, 2019
- Realizing Shared Decision-Making in PracticeJuly 25th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: